Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katrin Bernöster"'
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-4 (2017)
Abstract Indatuximab ravtansine is a monoclonal antibody-linked cytotoxic agent that specifically targets CD138-expressing cells. Monotherapy has been shown to significantly inhibit multiple myeloma tumour growth in vivo and improve host survival. He
Externí odkaz:
https://doaj.org/article/4fdcd3bf84d74c5aadc3179e988ff8ec
Autor:
Peter Herbener, Kurt Schönfeld, Martin König, Matthias Germer, Jude M Przyborski, Katrin Bernöster, Jörg Schüttrumpf
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195823 (2018)
An increasing number of monoclonal antibodies and derivatives such as antibody-drug conjugates (ADC) are of the IgG1 and IgG4 isotype with distinct structural and functional properties. In cases where antibody-mediated cytotoxicity is not desired, Ig
Externí odkaz:
https://doaj.org/article/5cd5401408894dbc9333986fdcb6d1d0
Autor:
Katrin Bernöster, Martin König, Matthias Germer, Kurt Schönfeld, Jude M. Przyborski, Jörg Schüttrumpf, Peter Herbener
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195823 (2018)
PLoS ONE
PLoS ONE
An increasing number of monoclonal antibodies and derivatives such as antibody-drug conjugates (ADC) are of the IgG1 and IgG4 isotype with distinct structural and functional properties. In cases where antibody-mediated cytotoxicity is not desired, Ig
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 314(2)
Benzodiazepines are among the most effective drugs for the treatment of anxiety disorders. However, their use is limited by undesired side effects, including sedation, development of tolerance, and drug abuse. The aim of this study was to evaluate th
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-4 (2017)
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-4 (2017)
Indatuximab ravtansine is a monoclonal antibody-linked cytotoxic agent that specifically targets CD138-expressing cells. Monotherapy has been shown to significantly inhibit multiple myeloma tumour growth in vivo and improve host survival. Here, we sh